The Truth About Aging Clocks and Biomarkers | Dr. Matt Kaeberlein
About this episode
Ben Hopkins interviews Professor Matt Kaeberlein about the science of aging and longevity, discussing biological age clocks, health interventions, and the future of aging research.
In this episode, Ben Hopkins sits down with longevity scientist Professor Matt Kaeberlein to unpack the biggest questions in aging, health span, and the science of living longer. They cover the promise and pitfalls of biological age clocks, why resveratrol failed to live up to the hype, how to think about aging as entropy and resilience, and which interventions actually look promising today. Matt also explains where lifestyle, hormones, and medications like rapamycin, SGLT2 inhibitors, GLP-1 agonists, and more fit into a practical longevity strategy. If you’re interested in evidence-based longevity, proactive health, and the future of aging research, this conversation is packed with insights. 00:00 Intro 00:37 Are biological age clocks a breakthrough or a gimmick? 06:04 What is aging, really? 11:25 Resveratrol: signal or noise? 21:58 The biggest proven levers for health and lifespan 27:25 SGLT2 inhibitors, GLP-1s, and proactive medicine 38:28 Testosterone, hormones, and aging 51:01 Why rapamycin has been so misunderstood 55:13 Compound bets: what’s most promising? 60:50 What surprised Matt most in longevity science? 63:58 The Dog Aging Project and longevity research in dogs Learn…
More episodes of Degrees of Health
- Rethinking Biology: Energy and Information | Dr Nirosha Murugan
- The Surprising Lack of Breakthroughs in Life Extension Science Over 40 Years | Siim Land
- Women’s Metabolism Explained: Menstrual Cycles, PCOS, Ketogenic Diets & Postpartum Depression | Dr. Madison Kackley
- Revolutionising Health: The Power of Learning, Language, and Mitochondria | Professor Thomas Seager
Explore listener stats, chart rankings, contacts and more on the Degrees of Health podcast page.